Nanoform and Herantis sign Biologics Proof of Concept Agreement
Press release Nanoform Finland Plc February 9[th], 2021 08:10 a.m. Finnish time / 07:10 a.m. Swedish time Nanoform and Herantis sign Biologics Proof of Concept Agreement Helsinki, Finland – Nanoform Finland Plc, an innovative nanoparticle medicine enabling company, and Herantis Pharma Plc, an innovative clinical stage biotech company, today announced that they have signed a Biologics Proof of Concept Agreement for formulation Proof of Concept projects (PoCs) aiming to enhance nasal drug delivery to the brain of Herantis’ CDNF therapies for Parkinson’s disease using Nanoform’s